|
Catalog Number
|
GTX47979-PRO
(
0
)
|
|
Product Name
|
Nanog-TAT Recombinant Protein
|
| Full Name | Nanog homeobox |
| Product Description | Recombinant Human Nanog-TAT protein |
| Background | Nanog is a regulatory protein that is associated with undifferentiated pluripotent cells. The expression of Nanog, which is suppressed in all adult tissues, is restricted to embryonic stem cells and to certain pluripotent cancer cells. Decreased expression of Nanog is strongly correlated with cell differentiation. Nanog, most likely, acts as an intracellular regulator, which helps maintain pluripotency and self renewal via a STAT3 independent pathway. The introduction of Nanog, along with Sox2, Oct4, Lin28, into primary human fibroblasts was sufficient to confer a pluripotent state upon the fibroblast genome. The reprogrammed cells thus obtained resemble ESC in morphology and gene expression. Protein transduction using TAT fusion proteins represents an alternative methodology for introducing transcription factors into primary as well as transformed cells. Recombinant human Nanog-TAT is a 36.2 kDa protein, which is synthesized as a 304 amino acid polypeptide plus a 13- residue C-terminal TAT peptide. |
| Target | Nanog-TAT |
| Species | Human |
| Expression System | E. coli |
| Applications | ELISA, WB |
| Application Note | Endotoxin level is less than 0.1 ng per ug (1EU/ug). |
| Form Supplied | Lyophilized powder |
| Purification Note | Greater than 95% by SDS-PAGE gel and HPLC analyses. |
| Purity | Greater than 95% by SDS-PAGE gel and HPLC analyses. |
| Storage Instruction | The lyophilized Nanog-TAT recombinant protein is stable for at least 2 years from date of receipt at -20ºC. Reconstituted Nanog-TAT is stable for at least 3 months when stored in working aliquots with a carrier protein at -20ºC. As with any protein, expos |
| Notes | For In vitro laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption. |
| ResearchArea | |
|